Cell cycle dependent expression and stability of the nuclear protein detected by Ki‐67 antibody in HL‐60 cells

Cell Proliferation

Volumn 25, Issue 1, 1992, Pages 31-40

  Bruno, S ^a   Darzynkiewicz, Z ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; CYCLOHEXIMIDE; MONOCLONAL ANTIBODY KI 67; VINBLASTINE;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL KINETICS; CELL NUCLEUS; CELL STRAIN HL 60; DNA CONTENT; GENE EXPRESSION; HALF LIFE TIME; HUMAN; HUMAN CELL; MITOSIS; MITOSIS INHIBITION; PROTEIN SYNTHESIS;

ANTIBODIES; CELL CYCLE; CELL NUCLEUS; CYCLOHEXIMIDE; DNA; GENE EXPRESSION; HUMAN; KI-67 ANTIGEN; NUCLEAR PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0026596029     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.1992.tb01435.x     Document Type: Article

References (36)

1. Simultaneous staining of exponentially growing versus plateau phase cells with the proliferation‐associated antibody Ki‐67 and propidium iodide: analysis by flow cytometry
2. Identification of proliferating cells by Ki‐67 antibody
3. Analysis of proliferation‐associated antigens
4. Cell cycle dependent distribution of the proliferation‐associated Ki 67 antigen in human embryonic lung cells
5. nmor growth fraction estimation, perturbation, and prognostication
6. Changes in cell nuclei during S phase: Progressive chromatin condensation and altered expression of the proliferation associated nuclear proteins Ki‐67, cyclin (PCNA), p105 and p34
7. RNA content, a feature correlated with cell kinetics and tumor prognosis
8. Acid denaturation of DNA in situ as a probe of chromatin structure
9. The cell cycle. Application of flow cytometry in studies of cell reproduction
10. Ki‐67 labeling index is a more reliable measure of solid tumor proliferative activity than tritiated thymidinc labeling
11. Regulation of protein synthcsis in mammalian cells. II. Inhibition of protein synthesis at the level of initiation during mitosis
12. Prognostic significance of proliferation associated nucleolar antigen P120 in human breast carcinoma
13. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
14. Cell cycle analysis of a cell proliferation‐associated human nuclear antigen defined by the monoclonal antibody Ki‐67
15. Immunobiochemical and molecular biologic characterization of the cell proliferation‐associated nuclear antigen that is defined by monoclonal antibody Ki‐67
16. Flow cytokinetics
17. Evaluation of cell proliferation in breast carcinoma. Comparison of KI‐67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count
18. Imniunoelectron‐microscopic localization of a proliferation‐associated antigen Ki‐67 in MCF‐7 cells
19. Washless double staining of a nuclear antigen (Ki‐67 or bromodeoxyuridine) and DNA in unfixed nuclei
20. Kinetic aspects of Ki‐67 antigen expression in a normal cell line
21. Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes
22. Autoradiographic analysis of cell proliferation in spontaneous breast cancer of C3H mouse. III. The growth fraction
23. 1 interval in the mammalian cell cycle: dual control by mass accumulation and stage‐specific activities
24. cde2
25. Assessment of cell proliferation in colorectal carcinomas using the monoclonal antibody Ki‐67. Correlation with pathohistologic criteria and influence of irradiation
26. The cell cycle associated change of the Ki‐67 reactive nuclear antigen expression
27. Relationship between labeling indices of Ki‐67 and BrdUrd in human malignant tumors
28. Assignment of the gene(s) involved in the expression of the proliferation‐related Ki‐67 antigen to human chromosome 10
29. Determination of the growth fraction in cell suspension by flow cytometry using the monoclonal antibody Ki‐67
30. In situ evaluation of growth fraction determined by monoclonal antibody KI‐67 and ploidy in surgical resected non small cell lung cancers
31. Effects of inhibition of RNA or protein synthesis on CHO cell cycle progression
32. Nuclear distribution of the Ki‐67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells
33. Ki‐67 detects a nuclear matrix‐associated proliferation‐related antigen. I. Intracellular localization during interphase
34. Ki‐67 detects a nuclear matrix‐associated proliferation‐related antigen. II. Localization in mitotic cells and association with chromosomes
35. Cell cycle dependent reactivity with the monoclonal antibody Ki‐67 during myeloid cell differentiation
36. Growth fractions in gastric carcinomas determined with monoclonal antibody Ki‐67